Significant Ownership of BIOS Fund III, LP
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for BIOS Fund III, LP focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ John Fucci - John Fucci/Attorney-in-Fact
- Manager location
- Fort Worth, TX
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow BIOS Fund III, LP with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from BIOS Fund III, LP
Significant Ownership of BIOS Fund III, LP
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| RNTX | OPUS GENETICS, INC. | Common Stock, $0.0001 par value per share | 6.2% | $5,156,801 | 3,683,429 | BIOS EQUITY PARTNERS III, LP | 05 May 2025 | ||
| IRD | Opus Genetics, Inc. | Common Stock, $0.0001 par value per share | 4.5% | $18,122,471 | 3,683,429 | AARON G.L. FLETCHER | 12 May 2026 |
Schedules 13D/G Reported by BIOS Fund III, LP:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.